Jänne PA - Search Results

1

Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.

Nishino M, Chambers ES, Chong CR, Ramaiya NH, Gray SW, Marcoux JP, Hatabu H, Jänne PA, Hodi FS, Awad MM. Nishino M, et al. Among authors: janne pa. Cancer Immunol Res. 2016 Apr;4(4):289-93. doi: 10.1158/2326-6066.CIR-15-0267. Epub 2016 Feb 10. Cancer Immunol Res. 2016. PMID: 26865455 Free PMC article.

2

Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment during pregnancy.

Jänne PA, Rodriguez-Thompson D, Metcalf DR, Swanson SJ, Greisman HA, Wilkins-Haug L, Johnson BE. Jänne PA, et al. Oncology. 2001;61(3):175-83. doi: 10.1159/000055371. Oncology. 2001. PMID: 11574771 Review.

3

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.

Jänne PA, Taffaro ML, Salgia R, Johnson BE. Jänne PA, et al. Cancer Res. 2002 Sep 15;62(18):5242-7. Cancer Res. 2002. PMID: 12234991

4

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.

Jänne PA, Freidlin B, Saxman S, Johnson DH, Livingston RB, Shepherd FA, Johnson BE. Jänne PA, et al. Cancer. 2002 Oct 1;95(7):1528-38. doi: 10.1002/cncr.10841. Cancer. 2002. PMID: 12237922 Free article.

5

Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study.

Wirth LJ, Lucca J, Ostler P, Fidias P, Lynch C, Jänne PA, Herbst RS, Johnson BE, Sugarbaker DJ, Mathisen DJ, Lukanich JM, Choi NC, Berman SM, Skarin AT. Wirth LJ, et al. Among authors: janne pa. Clin Cancer Res. 2003 May;9(5):1698-704. Clin Cancer Res. 2003. PMID: 12738723 Clinical Trial.

6

The role of epidermal growth factor receptor in advanced non-small cell lung carcinoma.

Jänne PA. Jänne PA. Ann Med. 2003;35(7):450-7. doi: 10.1080/07853890310010889. Ann Med. 2003. PMID: 14649327 Review.

7

Concurrent docetaxel and thoracic radiation in non-small-cell lung cancer.

Jänne PA, Skarin AT. Jänne PA, et al. Clin Lung Cancer. 2002 May;3 Suppl 2:S37-41. doi: 10.3816/clc.2002.s.012. Clin Lung Cancer. 2002. PMID: 14720346

8

Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study.

Jänne PA, Gurubhagavatula S, Yeap BY, Lucca J, Ostler P, Skarin AT, Fidias P, Lynch TJ, Johnson BE. Jänne PA, et al. Lung Cancer. 2004 May;44(2):221-30. doi: 10.1016/j.lungcan.2003.12.014. Lung Cancer. 2004. PMID: 15084387 Clinical Trial.

9

Basic treatment considerations using chemotherapy for patients with small cell lung cancer.

Johnson BE, Jänne PA. Johnson BE, et al. Among authors: janne pa. Hematol Oncol Clin North Am. 2004 Apr;18(2):309-22. doi: 10.1016/j.hoc.2003.12.008. Hematol Oncol Clin North Am. 2004. PMID: 15094173 Review. No abstract available.

10

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M. Paez JG, et al. Among authors: janne pa. Science. 2004 Jun 4;304(5676):1497-500. doi: 10.1126/science.1099314. Epub 2004 Apr 29. Science. 2004. PMID: 15118125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

476 results

Search Page